Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 12:02 PM View:  | Ashman Philip President of Int'l Operations | Alimera Sciences Inc (ALIM) | 26-Mar-24 | Payment of Exercise | 12,103 | $3.83 | $46,354.50 | (9%) 130.38K to 118.27K | |
| 11-Jan-24 12:49 PM View: | Ashman Philip President of Int'l Operations | Alimera Sciences Inc (ALIM) | 10-Jan-24 | Payment of Exercise | 2,938 | $3.86 | $11,343.60 | (2%) 133.31K to 130.38K | |
| 04-Oct-23 4:45 PM View: | Werner Jason M. Chief Operating Officer | Alimera Sciences Inc (ALIM) | 02-Oct-23 | Grant | 225,000 | -- | -- | 100% 0 to 225.0K | |
| 04-Oct-23 4:38 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 02-Oct-23 | Grant | 400,000 | -- | -- | 124% 322.52K to 722.52K | |
| 15-Sep-23 4:05 PM View: | Caligan Partners Lp 10% Owner | Alimera Sciences Inc (ALIM) | 14-Sep-23 | Private Purchase | 579,000 | $3.39 | $1,962,810.00 | 2% 33.09M to 33.67M | |
| 15-Sep-23 4:05 PM View: | Caligan Partners Lp 10% Owner | Alimera Sciences Inc (ALIM) | 14-Sep-23 | Sale | 579,000 | $3.39 | $1,962,810.00 | (2%) 33.67M to 33.09M | |
| 17-Aug-23 7:01 PM View: | Caligan Partners Lp 10% Owner | Alimera Sciences Inc (ALIM) | 15-Aug-23 | Conversion | 16,356,400 | $1.77 | $28,975,700.00 | 421% 3.88M to 20.24M | |
| 17-Aug-23 8:18 PM View: | Morgan Adam Director 10% Owner | Alimera Sciences Inc (ALIM) | 15-Aug-23 | Conversion | 11,948,900 | $1.80 | $21,483,000.00 | 720% 1.66M to 13.61M | |
| 19-May-23 5:17 PM View: | Morgan Adam Director 10% Owner | Alimera Sciences Inc (ALIM) | 17-May-23 | Private Purchase | 1,401,900 | $1.70 | $2,383,230.00 | 544% 257.75K to 1.66M | |
| 28-Mar-23 7:18 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 26-Mar-23 | Grant | 186,000 | -- | -- | 136% 136.52K to 322.52K | |
| 28-Mar-23 7:20 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 26-Mar-23 | Grant | 103,000 | -- | -- | 340% 30.32K to 133.31K | |
| 28-Mar-23 7:21 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 26-Mar-23 | Grant | 68,000 | -- | -- | 166% 40.88K to 108.88K | |
| 28-Mar-23 7:23 PM View: | Skibsted Russell Chief Financial Officer & SVP | Alimera Sciences Inc (ALIM) | 26-Mar-23 | Grant | 58,000 | -- | -- | 331% 17.5K to 75.5K | |
| 28-Mar-23 5:13 PM View: | Palo Alto Investors, LLC 10% Owner | Alimera Sciences Inc (ALIM) | 24-Mar-23 | Sale | 200,919 | $1.56 | $314,117.00 | (100%) 200.92K to 0 | |
| 06-Feb-23 4:01 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 03-Feb-23 | Payment of Exercise | 2,889 | $2.81 | $8,119.25 | (9%) 33.2K to 30.32K | |
| 10-Jan-23 4:29 PM View: | Skibsted Russell Chief Financial Officer & SVP | Alimera Sciences Inc (ALIM) | 09-Jan-23 | Grant | 17,500 | -- | -- | 100% 0 to 17.5K | |
| 02-Nov-22 5:16 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 31-Oct-22 | Grant | 372 | $4.44 | $1,650.56 | 1% 31.81K to 32.19K | 7% |
| 02-Nov-22 5:11 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 31-Oct-22 | Grant | 500 | $4.44 | $2,218.50 | 1% 40.38K to 40.88K | 7% |
| 02-Nov-22 5:05 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 31-Oct-22 | Grant | 500 | $4.44 | $2,218.50 | < 1% 136.02K to 136.52K | 7% |
| 03-May-22 4:19 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 29-Apr-22 | Grant | 500 | $3.76 | $1,878.50 | < 1% 135.52K to 136.02K | |
| 03-May-22 4:02 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 29-Apr-22 | Grant | 426 | $3.76 | $1,600.48 | 1% 31.39K to 31.81K | |
| 03-May-22 4:11 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 29-Apr-22 | Grant | 500 | $3.76 | $1,878.50 | 1% 39.88K to 40.38K | |
| 10-Feb-22 9:11 PM View: | Morgan Stanley 10% Owner | Alimera Sciences Inc (ALIM) | 08-Feb-22 | Market Sale | 250,000 | $4.55 | $1,137,500.00 | (31%) 807.55K to 557.55K | (5%) |
| 12-Jan-22 10:03 AM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 10-Jan-22 | Payment of Exercise | 1,175 | $4.65 | $5,463.75 | (3%) 34.38K to 33.2K | (2%) |
| 06-Jan-22 4:23 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 04-Jan-22 | Grant | 25,000 | -- | -- | 23% 110.52K to 135.52K | |
| 06-Jan-22 6:17 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 04-Jan-22 | Grant | 8,750 | -- | -- | 28% 31.13K to 39.88K | |
| 06-Jan-22 5:58 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 04-Jan-22 | Grant | 15,000 | -- | -- | 77% 19.38K to 34.38K | |
| 06-Jan-22 5:27 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 04-Jan-22 | Grant | 8,750 | -- | -- | 39% 22.64K to 31.39K | |
| 16-Dec-21 7:36 AM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 15-Dec-21 | Market Purchase | 484 | $4.50 | $2,176.98 | < 1% 110.03K to 110.52K | 2% |
| 07-Dec-21 10:33 AM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 03-Dec-21 | Market Purchase | 5,000 | $4.80 | $23,981.00 | 5% 105.03K to 110.03K | (2%) |
| 06-Dec-21 11:24 AM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 02-Dec-21 | Market Purchase | 5,000 | $4.89 | $24,427.50 | 5% 100.03K to 105.03K | (5%) |
| 08-Nov-21 4:01 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 05-Nov-21 | Market Purchase | 1,400 | $5.50 | $7,700.00 | 1% 98.63K to 100.03K | 4% |
| 08-Nov-21 4:01 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 04-Nov-21 | Market Purchase | 10,086 | $4.41 | $44,446.00 | 11% 88.55K to 98.63K | 29% |
| 04-Nov-21 8:09 PM View: | Largent James R Director | Alimera Sciences Inc (ALIM) | 03-Nov-21 | Market Purchase | 10,000 | $4.31 | $43,090.00 | 333% 3.0K to 13.0K | 3% |
| 04-Nov-21 4:50 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 03-Nov-21 | Market Purchase | 5,000 | $4.08 | $20,399.00 | 25% 19.96K to 24.96K | 9% |
| 04-Nov-21 4:43 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 03-Nov-21 | Market Purchase | 28,005 | $4.45 | $124,745.00 | 46% 60.54K to 88.55K | (< 1%) |
| 04-Nov-21 4:31 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 03-Nov-21 | Market Purchase | 5,000 | $4.08 | $20,391.50 | 19% 26.13K to 31.13K | 9% |
| 02-Nov-21 4:47 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 29-Oct-21 | Grant | 399 | $3.76 | $1,499.04 | 2% 19.57K to 19.96K | |
| 02-Nov-21 4:37 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 29-Oct-21 | Grant | 500 | $3.76 | $1,878.50 | < 1% 60.04K to 60.54K | |
| 02-Nov-21 4:58 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 29-Oct-21 | Grant | 500 | $3.76 | $1,878.50 | 2% 25.63K to 26.13K | |
| 17-Sep-21 4:49 PM View: | Halak Brian K Director | Alimera Sciences Inc (ALIM) | 17-Sep-21 | Acquisition (other) | 215 | -- | -- | 192% 0.11K to 0.33K | |
| 04-May-21 4:12 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 30-Apr-21 | Grant | 421 | $3.56 | $1,499.39 | 2% 19.14K to 19.57K | |
| 04-May-21 4:17 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 30-Apr-21 | Grant | 500 | $3.56 | $1,780.75 | < 1% 59.54K to 60.04K | |
| 04-May-21 4:26 PM View: | Holland David Chief Marketing Officer & SVP | Alimera Sciences Inc (ALIM) | 30-Apr-21 | Grant | 500 | $3.56 | $1,780.75 | 2% 25.13K to 25.63K | |
| 12-Apr-21 4:56 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 08-Apr-21 | Market Sale | 45 | $9.62 | $432.90 | (< 1%) 19.42K to 19.38K | (< 1%) |
| 10-Mar-21 4:18 PM View: | Jones John Philip Chief Financial Officer | Alimera Sciences Inc (ALIM) | 09-Mar-21 | Payment of Exercise | 1,164 | $7.64 | $8,892.96 | (6%) 20.31K to 19.14K | 2% |
| 10-Mar-21 4:10 PM View: | Holland David Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 08-Mar-21 | Payment of Exercise | 1,935 | $7.42 | $14,348.20 | (7%) 27.07K to 25.13K | (1%) |
| 08-Mar-21 5:31 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 04-Mar-21 | Payment of Exercise | 2,533 | $7.77 | $19,681.40 | (12%) 21.96K to 19.42K | (2%) |
| 11-Jan-21 4:45 PM View: | Ashman Philip Chief Operating Officer & SVP | Alimera Sciences Inc (ALIM) | 07-Jan-21 | Grant | 10,000 | -- | -- | 84% 11.96K to 21.96K | |
| 11-Jan-21 5:16 PM View: | Eiswirth Richard S Jr President and CEO Director | Alimera Sciences Inc (ALIM) | 07-Jan-21 | Grant | 17,500 | -- | -- | 42% 42.04K to 59.54K |
